MVista® Coccidioides Antigen Quantitative EIA

Test Code

COCCID AG MV315(O)

CPT Codes
87449<br>This test is not available for New York patient testing.

Preferred Specimen

2 mL serum, spun

Minimum Volume

1.2 mL serum or plasma • 0.5 mL urine, BAL, or other body fluids • 0.8 mL CSF

Other Acceptable Specimens

Plasma collected in: sodium heparin (green-top) tube, or EDTA (lavender-top) tube, or 3.2% sodium citrate (light blue-top) tube • CSF • Urine • Bronchial lavage/wash • Other body fluids collected in a sterile leak-proof container or vial

Instructions

Serum: Allow blood to clot for 30 minutes, then centrifuge. Pipette serum into a transport tube.
Plasma: Centrifuge for 15 minutes and pipette into a transport tube.

Note: Ship next day service Monday-Friday delivery.

Transport Container

Transport tube

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 14 days
Refrigerated: 14 days
Frozen: Indefinitely

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)

Specimen is too viscous to pipette • Tissue, sputum, bronchial brushings, stool, FNA, biopsy, tracheal or bone marrow aspirate

Methodology
Quantitative Sandwich Enzyme Immunoassay

FDA Status
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Setup Schedule

Set up: Mon-Fri; Report available: 1-2 days

Limitations

The result is not intended to be used as the sole means for clinical diagnosis or patient management decisions. Cross reactions are seen with histoplasmosis, blastomycosis and paracoccidioidomycosis.
Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.

Reference Range

See Laboratory Report

Clinical Significance

The coccidioides quantitative antigen test aids in the diagnosis of coccidioidomycosis. Monitoring the coccidioidomycosis helps determine when treatment can be stopped and to diagnose relapse.

Last Updated: July 28, 2020

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.